On Sep. 19, 2017, Molecular Devices, a provider of high-performance bioanalytical measurement systems, software, and consumables, formed a partnership with Cytena, a start-up life sciences company focused on single-cell technologies, to launch the CloneSelect Single-Cell Printer (SCP) in North AOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.